Pag-aaral pangklinika para sa Lupus sa Tennessee
13 pag-aaral para sa Lupus ang naghahanap ng mga kalahok sa mga site sa Tennessee.
Mga Lungsod sa Tennessee
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50001, Jackson
- Sl0044 50693, Murfreesboro
Nagre-recruitPhase 3
Edad 16 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
Nagre-recruitPhase 2
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06133972A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Memphis
- Research Site, Memphis
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- West Tennessee Research Institute, Jackson
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- West Tennessee Research Institute - Jackson /ID# 284561, Jackson
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07607964A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Murfreesboro Medical Clinic, Murfreesboro
Nagre-recruitObservasyonal na pag-aaral
Edad 16 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07175285A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Private Practice - Dr. Ramesh C. Gupta /ID# 275826, Memphis
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06977724A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Memphis
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07260877A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Regional One Health, Memphis
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 5, 2026 · NCT066133602-HOBA in Systemic Lupus Erythematosus
- Vanderbilt University Medical Center, Nashville
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update May 22, 2026 · NCT07225543A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Regional One Health, Memphis
Nagre-recruitPhase 1
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Vanderbilt University Medical Center, Nashville
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT05934149Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.